| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Shanghai MicroPort Endovascular MedTech Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥174.88 |
| 52 Week High | CN¥210.30 |
| 52 Week Low | CN¥147.01 |
| Beta | 0.33 |
| 1 Month Change | 0.19% |
| 3 Month Change | -0.64% |
| 1 Year Change | 0.97% |
| 3 Year Change | -47.59% |
| 5 Year Change | n/a |
| Change since IPO | 10.47% |
Recent News & Updates
Shareholder Returns
| 688016 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 2.6% | 4.3% | -0.3% |
| 1Y | 1.0% | -18.6% | -14.6% |
Return vs Industry: 688016 exceeded the CN Medical Equipment industry which returned -18.6% over the past year.
Return vs Market: 688016 exceeded the CN Market which returned -14.6% over the past year.
Price Volatility
| 688016 volatility | |
|---|---|
| 688016 Average Weekly Movement | 6.3% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 688016 has not had significant price volatility in the past 3 months.
Volatility Over Time: 688016's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 908 | Qing Zhu | www.endovastec.com |
Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, and sale of aortic and peripheral vascular medical devices in China and internationally. Its products include thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems, aortic dissection, percutaneous transluminal angioplasty, and balloon catheters, as well as accessories, such as balloon inflation catheter.
Shanghai MicroPort Endovascular MedTech Co., Ltd. Fundamentals Summary
| 688016 fundamental statistics | |
|---|---|
| Market cap | CN¥14.47b |
| Earnings (TTM) | CN¥492.43m |
| Revenue (TTM) | CN¥1.19b |
29.4x
P/E Ratio12.2x
P/S RatioIs 688016 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688016 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.19b |
| Cost of Revenue | CN¥285.93m |
| Gross Profit | CN¥901.27m |
| Other Expenses | CN¥408.84m |
| Earnings | CN¥492.43m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 27, 2024
| Earnings per share (EPS) | 5.95 |
| Gross Margin | 75.92% |
| Net Profit Margin | 41.48% |
| Debt/Equity Ratio | 0% |
How did 688016 perform over the long term?
See historical performance and comparison